K. Kosmatopoulos

Protection against lethal viral infection by vaccination with nonimmunodominant peptides

Mohammed Oukka, Jean‐Claude Manuguerra, N Livaditis et al. · The Journal of Immunology · 1996 · 82 citations · Full text

Life Sciences, Immunology, Infectious Diseases +11

A Phase I Study of the Optimized Cryptic Peptide TERT<sub>572Y</sub> in Patients with Advanced Malignancies

Dimitriοs Mavroudis, Irena Bolonakis, Sébastien Cornet et al. · Oncology · 2006 · 55 citations

Medicine, Oncology, Pharmacology +13

Clinical outcome of patients with various advanced cancer types vaccinated with an optimized cryptic human telomerase reverse transcriptase (TERT) peptide: results of an expanded phase II study

Eleni‐Kyriaki Vetsika, Soultana Christou, Dora Hatzidaki et al. · Annals of Oncology · 2011 · 50 citations · Full text

Medicine, Immunology, Oncology +16

Chimeric peptides: a new approach to enhancing the immunogenicity of peptides with low MHC class I affinity: application in antiviral vaccination

Sophie Tourdot, Mohamed Oukka, Jean‐Claude Manuguerra et al. · The Journal of Immunology · 1997 · 46 citations

Life Sciences, Immunology, Infectious Diseases +17

Anti-receptor anti-MHC cytotoxic T lymphocytes: their role in the resistance to graft vs host reaction.

K. Kosmatopoulos, S. Orbach‐Arbouys · The Journal of Immunology · 1987 · 23 citations · Full text

Life Sciences, Immunology, Pathology +15